Year-over-year earnings per share growth for the last twelve months: novabay.com (NBY)

Official company branding of NovaBay (NBY)

Regular pharmacy sales provide NovaBay Pharmaceuticals (NBY) with a predictable cash flow. Quarterly earnings per share dynamics reflect current market volatility, where the 62.60 mark characterizes this parameter. The uniqueness of the Avenova brand lies in the safe elimination of toxins. However, a chronic lack of profitability and fierce competition in the over-the-counter segment are forcing the company to undergo active asset restructuring.

NovaBay Pharmaceuticals Inc. (NBY) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 04/18/2026

NBY (novabay.com): analytical breakdowns and indicator data

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Fundamental valuation:NovaBay - NBY
Flagship merchandise of NovaBay Pharmaceuticals

The market evaluates the potential of NovaBay Pharmaceuticals (NBY) through the lens of commercializing antibacterial innovations, where earnings per share dynamics serve as a benchmark for the effective implementation of over-the-counter products. By analyzing the quarterly EPS growth rate, investors observe a smoothed net income curve that reflects the business's speed of adaptation to market shocks, defining the security's status as a high-risk asset with a pronounced technological driver.

Competitor analysis

Alcon Corp (ALC) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Bausch Health (BLCO)|Year-over-year earnings per share growth for the last twelve months glaukos.com|Apellis Pharmaceuticals (APLS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BLTE|OCUL - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth HROW (Harrow Inc)|Year-over-year net earnings per share change for the last twelve months Viridian Corp (VRDN)|LENZ - Year-over-year earnings per share growth for the last twelve months|Oculis - Year-over-year earnings per share growth rate for the last twelve months|EyePoint Pharmaceuticals (EYPT) - Year-over-year earnings per share growth for the last twelve months|Kodiak Sciences Inc (KOD) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ALDX|KALA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth IRD|OKYO: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adverum Biotechnologies ADVM|Quarterly EPS earnings growth Outlook Pharma OTLK|Clearside Biomedical - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Year-over-year earnings per share growth for the last twelve months|Eyenovia Inc. - Year-over-year earnings per one share growth for the last 12 months|GHSI (Guardion Health Sciences) - Quarterly EPS earnings growth|Ocuphire Pharma - Year-over-year net earnings per share trend for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OPT (Opthea)